北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (5): 760-767. doi: 10.3969/j.issn.1671-167X.2017.05.004

• 论著 • 上一篇    下一篇

多重竞争性荧光PCR检测X连锁Alport综合征大片段缺失突变

王芳, 张琰琴, 丁洁, 俞礼霞   

  1. 北京大学第一医院儿科, 北京 100034
  • 收稿日期:2017-06-22 出版日期:2017-10-18 发布日期:2017-10-18
  • 基金资助:
    国家十二五科技支撑计划(2012BAI03B02)、国家重点研发计划(2016YFC0901505)、国家自然科学基金(81070545)、北京市自然科学基金(7102148)和儿科遗传性疾病分子诊断与研究北京市重点实验室(Z141107004414036)资助

Detection of large deletions in X linked Alport syndrome using competitive multiplex fluorescence polymerase chain reaction

WANG Fang, ZHANG Yan-qin, DING Jie, YU Li-xia   

  1. Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
  • Received:2017-06-22 Online:2017-10-18 Published:2017-10-18
  • Supported by:
    Supported by the National Twelfth Five-Year-Plan for Scientific and Technological Support Project (2012BAI03B02), the National Key Research and Development Program of China (2016YFC0901505), the National Natural Science Foundation of China (81070545), the Beijing Nature Science Foundation (7102148), and the Beijing Key Laboratory of Molecular Diagnosis and Study on Pediatric Genetic Diseases (Z141107004414036)

摘要: 目的 探讨多重竞争性荧光PCR在X连锁Alport综合征分子诊断中的应用。方法 选择20例在北京大学第一医院确诊且未进行基因诊断的X连锁Alport综合征患者为研究对象,同时选择2例经多重连接依赖性探针扩增技术检测到COL4A5基因大片段缺失突变的患者作为阳性对照和1例经肾活检组织电子显微镜检查证实非Alport综合征的男性作为正常对照。首先应用多重竞争性荧光PCR技术扩增COL4A5基因53个外显子和4个参照基因,对于检测到COL4A5基因缺失第1外显子者,进而应用相同技术扩增COL4A5基因外显子1~4、COL4A6基因外显子1~4、两基因共用启动子以及3个参照基因;对于检测到拷贝数缺失者,应用琼脂糖凝胶电泳鉴定扩增后的PCR产物或直接测序。结果 两例阳性对照应用多重竞争性荧光PCR技术检测到的COL4A5基因缺失突变与应用多重连接依赖性探针扩增技术检测到的COL4A5基因缺失突变一致。20例患者中6例(30%)明确了基因型,其中2例患者具有累及COL4A5COL4A6两个基因5'端的大片段缺失,2例患者具有累及COL4A5基因30个外显子以上的大片段缺失,1例患者具有累及COL4A5基因至少1个外显子的大片段缺失,1例患者具有COL4A5基因缺失13个碱基的小的缺失突变,未检测到重复突变。结论 多重竞争性荧光PCR技术可用于检测X连锁 Alport 综合征大片段缺失突变,是对该病分子诊断检测方法的重要补充。

关键词: Alport综合征, X连锁, 大片段缺失突变, COL4A5基因, 多重竞争性荧光聚合酶链反应

Abstract: Objective: To evaluate the ability of multiplex competitive fluorescence polymerase chain reaction in detection of large deletion and duplication genotypes of X-linked Alport syndrome. Methods: Clinical diagnosis of X-linked Alport syndrome was based on either abnormal staining of type Ⅳ collagen α5 chain in the epidermal basement membrane alone or with abnormal staining of type Ⅳ collagen α5 chain in the glomerular basement membrane and Bowman’s capsule/ultrastructural changes in the glomerular basement membrane typical of Alport syndrome. A total of 20 unrelated Chinese patients (13 males and 7 females) clinically diagnosed as X-linked Alport syndrome were included in the study. Their genotypes were unknown. Control subjects included a male patient with other renal disease and two patients who had large deletions in COL4A5 gene detected by multiplex ligation-dependent probe amplification. Genomic DNA was isolated from peripheral blood leukocytes in all the participants. Multiplex competitive fluorescence polymerase chain reaction was used to coamplify 53 exons of COL4A5 gene and four reference genes in a single reaction. When a deletion removed exon 1 of COL4A5 gene was identified, the same method was used to coamplify the first 4 exons of COL4A5 and COL4A6 genes, a promoter shared by COL4A5 and COL4A6 genes, and three reference genes in a single reaction. Any copy number loss suggested by this method was verified by electrophoresis of corresponding polymerase chain reaction amplified products or DNA sequencing to exclude possible DNA variations in the primer regions. Results: Genotypes of two positive controls identified by multiplex competitive fluorescence polymerase chain reaction were consistent with those detected by multiplex ligation-dependent probe amplification. Deletions were identified in 6 of the 20 patients, including two large deletions removing the 5' part of both COL4A5 and COL4A6 genes with the breakpoint located in the second intron of COL4A6, two large deletions removing more than 30 exons of COL4A5 gene, one large deletion removing at least 1 exon of COL4A5 gene, and one small deletion involving 13 bps. No duplication was found. Conclusion: Our results show that multiplex competitive fluorescence polymerase chain reaction is a good alternative to classical techniques for large deletion genotyping in X-linked Alport syndrome.

Key words: Alport syndrome, X-linked, Large deletion, COL4A5 gene, Multiplex competitive fluorescence polymerase chain reaction

中图分类号: 

  • R729
[1] Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males[J]. J Am Soc Nephrol, 2000, 11(4): 649-657.
[2] Wang F, Zhao D, Ding J, et al. Skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of X-linked Alport’s syndrome[J]. J Mol Diagn, 2012, 14(6): 586-593.
[3] Kashtan CE, Ding J, Gregory M, et al. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport syndrome research collaborative[J]. Pediatr Nephrol, 2013, 28(1): 5-11.
[4] Bekheirnia MR, Reed B, Gregory MC, et al. Genotype-phenotype correlation in X-linked Alport syndrome[J]. J Am Soc Nephrol, 2010, 21(5): 876-883.
[5] Cheong HI, Park HW, Ha IS, et al. Mutational analysis of COL4A5 gene in Korean Alport syndrome[J]. Pediatr Nephrol, 2000, 14(2): 117-121.
[6] Kawai S, Nomura S, Harano T. The COL4A5 gene in Japanese Alport syndrome patients: spectrum of mutations of all exons. The Japanese Alport Network[J]. Kidney Int, 1996, 49(3): 814-822.
[7] Ceulemans S, van der Ven K, del-Favero J. Targeted screening and validation of copy number variations[J]. Methods Mol Biol, 2012, 838: 311-328.
[8] 张琰琴,赵丹,俞礼霞, 等. 多重连接依赖性探针扩增技术在X连锁Alport综合征基因诊断中的应用[J].中华医学杂志, 2012, 92(40): 2825-2829.
[9] Hertz JM, Juncker I, Marcussen N. MLPA and cDNA analysis improves COL4A5 mutation detection in X-linked Alport syndrome[J]. Clin Genet, 2008, 74(6): 522-530.
[10] Nabais Sá MJ, Fieremans N, de Brouwer APM, et al. Deletion of the 5' exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome[J]. J Med Genet, 2013, 50(11): 745-753.
[11] Nozu K, Minamikawa S, Yamada S, et al. Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis[J]. J Hum Genet, 2017, 62(7): 733-735.
[12] Nabais Sá MJ, Sampaio S, Oliveira A, et al. Collagen type Ⅳ-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families[J]. Clin Genet, 2015, 88(5): 462-467.
[13] Weber S, Strasser K, Rath S, et al. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy[J]. Pediatr Nephrol, 2016, 31(6): 941-955.
[14] Du R, Lu C, Jiang Z, et al. Efficient typing of copy number variations in a segmental duplication-mediated rearrangement hotspot using multiplex competitive amplification[J]. J Hum Genet, 2012, 57(8): 545-551.
[15] Wang F, Ding J, Guo S, et al. Phenotypic and genotypic features of Alport syndrome in Chinese children[J]. Pediatr Nephrol, 2000, 17(12): 1013-1020.
[16] Martin P, Heiskari N, Zhou J, et al. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing[J]. J Am Soc Nephrol, 1998, 9(12): 2291-2301.
[17] Savige J, Gregory M, Gross O, et al. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy[J]. J Am Soc Nephrol, 2013, 24(3): 364-375.
[18] Dahan K, Heidet L, Zhou J, et al. Smooth muscle tumors associated with X-linked Alport syndrome: carrier detection in females[J]. Kidney Int, 1995, 48(6): 1900-1906.
[19] Thielen BK, Barker DF, Nelson RD, et al. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth[J]. Hum Mutat, 2003, 22(5): 419.
[1] 杜燕燕,王健,贺兰,季丽娜,徐樨巍. 儿童川崎病合并轻微脑炎/脑病伴可逆性胼胝体压部病变综合征1例并文献复习[J]. 北京大学学报(医学版), 2022, 54(4): 756-761.
[2] 王芳,张琰琴,丁洁,俞礼霞. 多重竞争性荧光PCR检测X连锁Alport综合征大片段缺失突变[J]. 北京大学学报(医学版), 0, (): 760-767.
[3] 韩烨, 杜偲倩, 肖慧捷, 周颖, 丁洁, 丁娟娟, 崔一民. 他克莫司缓释剂治疗儿童原发性肾病综合征的药代动力学特点[J]. 北京大学学报(医学版), 0, (): 807-813.
[4] 韩烨, 杜偲倩, 肖慧捷, 周颖, 丁洁, 丁娟娟, 崔一民. 他克莫司缓释剂治疗儿童原发性肾病综合征的药代动力学特点[J]. 北京大学学报(医学版), 2017, 49(5): 807-813.
[5] 季丽娜, 耿海云, 晁爽. 儿童特异性日间尿频104例临床分析[J]. 北京大学学报(医学版), 2017, 49(5): 927-929.
[6] 季丽娜, 耿海云, 晁爽. 儿童特异性日间尿频104例临床分析[J]. 北京大学学报(医学版), 0, (): 0-封三.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!